Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA
Karn Wijarnpreecha, Donghee Kim, Pascale Raymond, et al.
European Journal of Gastroenterology & Hepatology (2019) Vol. 31, Iss. 9, pp. 1121-1128
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Soo Lim, Jin‐Wook Kim, Giovanni Targher
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 7, pp. 500-514
Closed Access | Times Cited: 150
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 24
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
Pegah Golabi, Lynn H. Gerber, James M. Paik, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100171-100171
Open Access | Times Cited: 98
Sarcopenia and fatty liver disease
Jung A Kim, Kyung Mook Choi
Hepatology International (2019) Vol. 13, Iss. 6, pp. 674-687
Closed Access | Times Cited: 90
Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
Changzhou Cai, Xin Song, Yishu Chen, et al.
Hepatology International (2019) Vol. 14, Iss. 1, pp. 115-126
Open Access | Times Cited: 87
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S43-S57
Open Access | Times Cited: 56
Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association
Uday C. Ghoshal, Sanjeev Sachdeva, Ujjala Ghoshal, et al.
Indian Journal of Gastroenterology (2022) Vol. 41, Iss. 5, pp. 483-507
Open Access | Times Cited: 48
Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S68-S78
Open Access | Times Cited: 43
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
Stergios A. Pοlyzos, Ilias D. Vachliotis, Christos S. Mantzoros
Metabolism (2023) Vol. 147, pp. 155676-155676
Closed Access | Times Cited: 33
Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis
Michael Harring, Pegah Golabi, James M. Paik, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 11, pp. 2876-2888.e5
Closed Access | Times Cited: 26
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Jiaqin Yuan, Jinglin Zhang, Qiang Luo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
Manu V. Chakravarthy, Mohammad Shadab Siddiqui, Mikael Forsgren, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 64
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
Maxime Nachit, Maxime De Rudder, Jean‐Paul Thissen, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 12, Iss. 1, pp. 144-158
Open Access | Times Cited: 58
Association of Sarcopenia and NAFLD: An Overview
Andrew A. Li, Donghee Kim, Aijaz Ahmed
Clinical Liver Disease (2020) Vol. 16, Iss. 2, pp. 73-76
Open Access | Times Cited: 57
Sarcopenia in nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality in the United States
Donghee Kim, Karn Wijarnpreecha, Keeryth K. Sandhu, et al.
Liver International (2021) Vol. 41, Iss. 8, pp. 1832-1840
Closed Access | Times Cited: 54
Lean nonalcoholic fatty liver disease and sarcopenia
Milian Chen, Ying Cao, Guang Ji, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Metabolic associated fatty liver disease and sarcopenia additively increase mortality: a real-world study
Qianwen Zhao, Yifan Yin, Yunlei Deng
Nutrition and Diabetes (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Rochelle Wong, Liyun Yuan
World Journal of Hepatology (2024) Vol. 16, Iss. 6, pp. 871-877
Open Access | Times Cited: 6
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
Annalisa Cespiati, Marica Meroni, Rosa Lombardi, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 182-182
Open Access | Times Cited: 23
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
Alessandra Musio, Federica Perazza, Laura Leoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7517-7517
Open Access | Times Cited: 15
Association of sarcopenia assessed by CT/MRI with treatment response and clinical outcomes in noncirrhotic primary biliary cholangitis patients
Leyu Zhou, Bo Li, Zhetao Wang, et al.
European Journal of Radiology (2025), pp. 112094-112094
Closed Access
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
Eugene Han, Yong‐ho Lee, Jae Seung Lee, et al.
Gut and Liver (2022) Vol. 16, Iss. 5, pp. 786-797
Open Access | Times Cited: 21
Pathobiology of Metabolic-Associated Fatty Liver Disease
Sherouk Fouda, Mohammed Sadiq Jeeyavudeen, Joseph M. Pappachan, et al.
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 3, pp. 405-416
Closed Access | Times Cited: 12
Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis
Chao Deng, Qifeng Ou, Xuee Ou, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e078933-e078933
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top